Association for Accessible Medicines office (accessiblemeds.org)
Generic drug industry pushes FDA to address nitrosamine impurities in a new way
In Feb. 2021, the FDA called on all drug manufacturers to improve the safety of the US drug supply and conduct risk assessments of all …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
